Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Samir R Kapadia Added: 5 months ago
TCT 23 - We are joined by Dr Samir Kapadia (Cleveland Clinic, Cleveland, OH) to discuss the findings of the WATCH-TAVR Trial (NCT03173534). WATCH-TAVR aimed to evaluate the safety and effectiveness of left atrial appendage occlusion with the WATCHMAN device to prevent stroke and bleeding in patients with atrial fibrillation (AF) who are undergoing transcatheter aortic valve replacement (TAVR)… View more
Author(s): Nicolas M Van Mieghem Added: 6 years ago
In this video, Dr Nicolas Van Mieghem discusses which patients he is performing TAVR in now. View more
Author(s): Nicolas M Van Mieghem Added: 6 years ago
In this video, Dr Nicolas Van Mieghem discusses the question; 'are we ready to be doing TAVR in low risk patients?'. View more
Author(s): Toby Rogers Added: 5 years ago
Dr Toby Rogers (MedStar Washington Hospital Center, Washington DC, US) discusses First-in-man testing of a dedicated closure device for transcaval access for TAVR Filmed on site at CRT 2019 by Radcliffe Cardiology Questions: 1. How often is transcaval access conducted, and for which patients? 2. Could you describe the novel device and how it works? 3. What data are you presenting at CRT 2019… View more
Author(s): Nicolas M Van Mieghem Added: 6 years ago
In this video, Dr Nicolas Van Mieghem discusses coronary revascularization pre-TAVR. View more
Author(s): Mark Young Lee , Srinath Chilakamarri Yeshwant , Sreedivya Chava , et al Added: 3 years ago
Aortic stenosis (AS) is the most common valvular heart disease in industrialised countries with a prevalence of about 5 % in the general population aged greater than 75 years. During the past decade, transcatheter aortic valve replacement (TAVR) has emerged as a valuable, minimally invasive treatment option for patients presenting with symptomatic severe AS, who due to their advanced age and… View more
Added: 6 months ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more
Job title: Professor of Medicine
Prof Duk-Woo Park is Professor in the Cardiovascular Medicine Division at Asan Medical Center, Seoul, Korea, and an Instructor in Medicine at the University of Ulsan College of Medicine.Prof Park has a particular interest in revascularization strategy (PCI vs. CABG for multivessel and left main disease), antiplatelet/antithrombotic strategey, transcatheter valve interventions (TAVR), major… View more
Job title: Interventional cardiologist
Verena Veulemans is an interventional cardiologist at University Hospital Düsseldorf, Germany. She joined the TAVR team in 2012 and has been a senior consultant since 2017. Dr Veulemans has led the interventional and transcatheter valve implantation/aortic disease research programme since 2018. She participates in many multicentre, international registries, and studies on TAVR and structural… View more
Job title: Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine. Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease. Her… View more